A national research initiative announced today will place the University of Wisconsin-Madison at the forefront of a revolution in imaging fostered by cryo-electron microscopy and cryo-electron tomography — technologies that can illuminate life at the atomic scale....
The race to develop a vaccine for the novel coronavirus that causes COVID-19 is happening with unprecedented speed, and will represent the largest global vaccination effort since the fight against polio nearly 70 years ago....
UW-Madison’s College of Engineering received its largest donation in the college’s history that will start a new scholarship program, help expand the undergraduate student body and create several professorships to keep top talent in Madison....
While economic uncertainty and the changes to daily life caused by the global pandemic have created countless challenges for business owners across many sectors, startup companies founded by UW–Madison innovators have managed to demonstrate resilience....
UW Health and the University of Wisconsin School of Medicine and Public Health (SMPH) are among the first sites in the country to study whether an investigational vaccine developed by the pharmaceutical company AstraZeneca can prevent COVID-19, the disease caused by the new coronavirus SARS-CoV-2....
PROGRAM GOAL: The goal of the Wisconsin Investment Pilot (WIP) Program is to support technology-based startup and emerging growth companies in the state of Wisconsin. This program was initiated by the Entrepreneurship and Innovation Committee to support early-stage companies trying to raise additional or bridge capital...
Waisman Biomanufacturing at the University of Wisconsin–Madison will begin manufacturing a new drug to treat and prevent COVID-19, developed by California-based biotech company GigaGen....
It’s like searching for a needle in a haystack. Except the haystack is human excrement. The needle, a tiny fragment of the tiny genetic material of a tiny virus that has, since December 2019, had a massive impact on the world....
The University of Wisconsin–Madison College of Agricultural and Life Sciences (CALS) recently selected seven projects for funding through the Dairy Innovation Hub initiative. The one-year grants will fund promising work in the Hub’s four priority areas: stewarding land and water resources; enriching human health and...
Applications are being accepted now from young companies that want to tell their stories to investors at our annual Wisconsin Early Stage Symposium #ESSWI, to be held Nov. 9-11 on a virtual platform....
Why is it that some COVID-19 patients become extremely ill and die, while others experience only mild symptoms? The molecular underpinnings of COVID-19 are the subject of a recent collaboration between the Morgridge Institute for Research, the University of Wisconsin-Madison, and Albany Medical College. ...
Many U.S. policymakers seem concerned about reopening bars, restaurants and health clubs closed during the COVID-19 pandemic. They should be at least as worried about restarting America’s education engine, which will best serve the economy – and young people – over time. The differences between how...